163 related articles for article (PubMed ID: 17002024)
1. [Direct drug delivery to the brain].
Chekhonin VP; Zhirkov IuA; Dmitrieva TB
Vestn Ross Akad Med Nauk; 2006; (8):30-7. PubMed ID: 17002024
[TBL] [Abstract][Full Text] [Related]
2. Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." The blood-brain barrier: a physical and conceptual challenge.
Hachinski V; Lee TY
Alzheimers Dement; 2009 Sep; 5(5):435-6. PubMed ID: 19751924
[No Abstract] [Full Text] [Related]
3. Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." Alzheimer's disease drugs: more than one barrier to breach.
Roher AE; Kokjohn TA
Alzheimers Dement; 2009 Sep; 5(5):437-8. PubMed ID: 19751925
[No Abstract] [Full Text] [Related]
4. Nanoparticle technology for drug delivery across the blood-brain barrier.
Lockman PR; Mumper RJ; Khan MA; Allen DD
Drug Dev Ind Pharm; 2002 Jan; 28(1):1-13. PubMed ID: 11858519
[TBL] [Abstract][Full Text] [Related]
5. Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.
Vlieghe P; Khrestchatisky M
Med Res Rev; 2013 May; 33(3):457-516. PubMed ID: 22434495
[TBL] [Abstract][Full Text] [Related]
6. Drug targeting to the brain.
de Boer AG; Gaillard PJ
Annu Rev Pharmacol Toxicol; 2007; 47():323-55. PubMed ID: 16961459
[TBL] [Abstract][Full Text] [Related]
7. Macromolecular drug transport into the brain using targeted therapy.
Lichota J; Skjørringe T; Thomsen LB; Moos T
J Neurochem; 2010 Apr; 113(1):1-13. PubMed ID: 20015155
[TBL] [Abstract][Full Text] [Related]
8. Targeted drug delivery to the brain; (blood-brain barrier, efflux, endothelium, biological transport).
Terasaki T; Pardridge WM
J Drug Target; 2000; 8(6):353-5. PubMed ID: 11328661
[No Abstract] [Full Text] [Related]
9. [Research advances in brain-targeted nanoscale drug delivery system].
Liu Y; Jiang C
Yao Xue Xue Bao; 2013 Oct; 48(10):1532-43. PubMed ID: 24417079
[TBL] [Abstract][Full Text] [Related]
10. The blood-brain barrier: bottleneck in brain drug development.
Pardridge WM
NeuroRx; 2005 Jan; 2(1):3-14. PubMed ID: 15717053
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease drug development and the problem of the blood-brain barrier.
Pardridge WM
Alzheimers Dement; 2009 Sep; 5(5):427-32. PubMed ID: 19751922
[TBL] [Abstract][Full Text] [Related]
12. Nanobiotechnology-based drug delivery to the central nervous system.
Jain KK
Neurodegener Dis; 2007; 4(4):287-91. PubMed ID: 17627131
[TBL] [Abstract][Full Text] [Related]
13. Exploiting the properties of biomolecules for brain targeting of nanoparticulate systems.
Cramer S; Rempe R; Galla HJ
Curr Med Chem; 2012; 19(19):3163-87. PubMed ID: 22612701
[TBL] [Abstract][Full Text] [Related]
14. Commentary on "Alzheimer's Disease Drug Development and the Problem of the Blood-Brain Barrier".
Simpkins JW
Alzheimers Dement; 2009 Sep; 5(5):433-4. PubMed ID: 19751923
[TBL] [Abstract][Full Text] [Related]
15. [New methods of drug delivery through the blood brain barrier].
Bruhn C
Dtsch Med Wochenschr; 2012 May; 137(21):p18. PubMed ID: 22622506
[No Abstract] [Full Text] [Related]
16. Pericytes and the blood-brain barrier: recent advances and implications for the delivery of CNS therapy.
Armulik A; Mäe M; Betsholtz C
Ther Deliv; 2011 Apr; 2(4):419-22. PubMed ID: 22826851
[TBL] [Abstract][Full Text] [Related]
17. Blood-brain barrier: an impediment to neuropharmaceuticals.
Henderson JT; Piquette-Miller M
Clin Pharmacol Ther; 2015 Apr; 97(4):308-13. PubMed ID: 25670372
[TBL] [Abstract][Full Text] [Related]
18. Translational aspects of blood-brain barrier transport and central nervous system effects of drugs: from discovery to patients.
de Lange EC; Hammarlund-Udenaes M
Clin Pharmacol Ther; 2015 Apr; 97(4):380-94. PubMed ID: 25670219
[TBL] [Abstract][Full Text] [Related]
19. The blood-brain barrier: Physiology and strategies for drug delivery.
Pandit R; Chen L; Götz J
Adv Drug Deliv Rev; 2020; 165-166():1-14. PubMed ID: 31790711
[TBL] [Abstract][Full Text] [Related]
20. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
Begley DJ
Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
